Charlotte's Web Holdings (CWBHF) Other Non-Current Assets (2020 - 2026)
Charlotte's Web Holdings (CWBHF) posted quarterly Other Non-Current Assets of $8000.0 for Q1 2026, down 98.28% year-over-year from $466000.0 in Q1 2025, and down 57.89% quarter-over-quarter from $19000.0 in Q4 2025.
Charlotte's Web Holdings (CWBHF) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has reported Other Non-Current Assets for 7 consecutive years, with $8000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 98.28% year-over-year to $8000.0; the TTM figure through Mar 2026 stood at $8000.0 (down 98.28% YoY), while the FY2025 annual figure was $19000.0, down 73.24% from the prior year.
- Other Non-Current Assets eased to $8000.0 in Q1 2026 per CWBHF's latest filing, from $19000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $6.0 million in Q3 2022 and bottomed at $8000.0 in Q1 2026.
- Historically, Other Non-Current Assets has averaged $1.4 million across 5 years, with a median of $703000.0 in 2023.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 179.83% — and 2026, when it sank 98.28%.
- Charlotte's Web Holdings' Other Non-Current Assets stood at $5.8 million in 2022, then sank by 87.82% to $703000.0 in 2023, then tumbled by 89.9% to $71000.0 in 2024, then tumbled by 73.24% to $19000.0 in 2025, then plunged by 57.89% to $8000.0 in 2026.
- Business Quant data shows CWBHF's Other Non-Current Assets at $8000.0 in Q1 2026, $19000.0 in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 13.00 Mn |
| 10 | Charlotte's Web Holdings | 67.01 Mn | 53.02 Mn | 5.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | 19,000.00 |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 416,000.00 |
| Mar 31, 2025 | 466,000.00 |
| Dec 31, 2024 | 71,000.00 |
| Sep 30, 2024 | 648,000.00 |
| Jun 30, 2024 | 534,000.00 |
| Mar 31, 2024 | 616,000.00 |
| Dec 31, 2023 | 703,000.00 |
| Sep 30, 2023 | 1.39 Mn |
| Jun 30, 2023 | 1.52 Mn |
| Mar 31, 2023 | 1.53 Mn |
| Dec 31, 2022 | 5.77 Mn |
| Sep 30, 2022 | 6.02 Mn |
| Jun 30, 2022 | 1.90 Mn |
| Mar 31, 2022 | 1.97 Mn |
| Dec 31, 2021 | 2.06 Mn |
| Dec 31, 2020 | 5.18 Mn |